logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Enzo Biochem Appoints Jason Apter As Chief Executive Officer

Aug 28, 20254 months ago

Position

Chief Executive Officer

Company

Enzo Life Sciences

Jason Apter
FarmingdaleBiotechnology

Description

Enzo Biochem has announced the appointment of Jason Apter as its new CEO. This move aims to support the company's next stage of growth and innovation in the life-science reagents market.

Company Information

Company

Enzo Life Sciences

Location

10 Executive Blvd

Farmingdale, New York, United States

About

Enzo Life Sciences, Inc. is a global leader in labeling and detection technologies, serving the life sciences research, drug discovery, drug development, and diagnostic markets for over 45 years. Founded in 1976 and based in Farmingdale, New York, the company focuses on enabling scientific innovation through its Life Sciences division, which supports a variety of applications from DNA analysis to whole cell and tissue analysis. The company offers a diverse product portfolio that includes antibodies, proteins, peptides, small molecules, genomic probes, assays, and labeling probes. These high-quality products are rigorously validated and are essential for target identification, gene expression analysis, protein biochemistry, and more. Enzo Life Sciences also provides custom manufacturing services, assay and validation testing, and GMP-certified services to assist biopharmaceutical and biotechnology companies in their drug development processes. With over 500 patents and more than 175,000 scientific citations, Enzo Life Sciences is committed to innovation and scientific rigor. The company emphasizes a customer-focused approach, positioning itself as "Scientists Enabling Scientists®" to support researchers in advancing scientific discovery.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months